Chardi Shahiya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chardi Shahiya has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Sergey Shityakov
Department of Biology and General Genetics, Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia
2 shared publications - Ekaterina V. Skorb
ITMO University Lomonosova St. 9
1 shared publication Gyula Kasza
Doctoral School of Food Science, Hungarian University of Agriculture and Life Sciences, Vill ´anyi Street 29-43, 1118, Budapest, Hungary
1 shared publication- Ikawati Karim
Agribusiness , Universitas Sulawesi Barat, Majane
1 shared publication - Samson Olusegun Afolabi
ITMO University Lomonosova St. 9
1 shared publication - Shahida Anusha Siddiqui
Campus Straubing for Biotechnology and Sustainability, Technical University of Munich, Essigberg 3, 94315 Straubing, Germany
1 shared publication
Latest Publications
- 24 November 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 2111-2131
Enhancing Drug Solubility and Bioavailability Through Cyclodextrin Inclusion Complexes: An Integrative Molecular Meta-Modeling Approach
Cyclodextrin inclusion complexes are increasingly used to increase drug solubility and bioavailability. This study integrates molecular modeling and meta-analysis to evaluate the pharmacokinetic performance and molecular stability of various cyclodextrin-drug systems. A meta-analysis of 11 studies was performed to assess effect sizes for maximum concentration ([ ] and area under curve (AUC), revealing substantial heterogeneity and overall improvement in drug exposure. Molecular docking, Molecular Dynamics (MD) simulations and free energy calculations were used to investigate the stability of the selected host-guest systems. Compared with the atorvastatin (ATV)/HP-[ ]-cyclodextrin system, the Compound K/[ ]-cyclodextrin complex exhibited the highest binding affinity with greater pharmacokinetic effect sizes. SBE-[ ]-CD was identified as the most effective cyclodextrin for enhancing bioavailability, whereas [ ]-CD was the least effective. To further explore these findings, four ligands, ATV, [ ]-caryophyllene, koumine and Compound K, were selected on the basis of their solubility (log[ ] values. A stronger affinity for SBE-[ ]-CD over [ ]-CD was observed for all tested compounds. This trend was confirmed through replicate MD simulations of Compound K and koumine, which revealed greater stability with SBE-[ ]-CD. These effects are attributed to the extended hydrophobic cavity of SBE-[ ]-CD and reduced electrostatic repulsion, emphasizing the role of molecular shape and hydrophobicity in complex stability. This integrated analysis highlights the potential of SBE-[ ]-CD to improve drug bioavailability through stable inclusion complex formation. These findings provide a mechanistic basis for cyclodextrin selection in formulation development. However, further clinical studies are needed to validate these computational predictions.
- 24 November 2025
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 25 (11) , 2111-2131
Enhancing Drug Solubility and Bioavailability Through Cyclodextrin Inclusion Complexes: An Integrative Molecular Meta-Modeling Approach
Cyclodextrin inclusion complexes are increasingly used to increase drug solubility and bioavailability. This study integrates molecular modeling and meta-analysis to evaluate the pharmacokinetic performance and molecular stability of various cyclodextrin-drug systems. A meta-analysis of 11 studies was performed to assess effect sizes for maximum concentration ([ ] and area under curve (AUC), revealing substantial heterogeneity and overall improvement in drug exposure. Molecular docking, Molecular Dynamics (MD) simulations and free energy calculations were used to investigate the stability of the selected host-guest systems. Compared with the atorvastatin (ATV)/HP-[ ]-cyclodextrin system, the Compound K/[ ]-cyclodextrin complex exhibited the highest binding affinity with greater pharmacokinetic effect sizes. SBE-[ ]-CD was identified as the most effective cyclodextrin for enhancing bioavailability, whereas [ ]-CD was the least effective. To further explore these findings, four ligands, ATV, [ ]-caryophyllene, koumine and Compound K, were selected on the basis of their solubility (log[ ] values. A stronger affinity for SBE-[ ]-CD over [ ]-CD was observed for all tested compounds. This trend was confirmed through replicate MD simulations of Compound K and koumine, which revealed greater stability with SBE-[ ]-CD. These effects are attributed to the extended hydrophobic cavity of SBE-[ ]-CD and reduced electrostatic repulsion, emphasizing the role of molecular shape and hydrophobicity in complex stability. This integrated analysis highlights the potential of SBE-[ ]-CD to improve drug bioavailability through stable inclusion complex formation. These findings provide a mechanistic basis for cyclodextrin selection in formulation development. However, further clinical studies are needed to validate these computational predictions.
- Open Access
- 10 August 2024
- Published by Elsevier in Current Research in Food Science
- Vol. 9, 100818
A critical review of consumer responsibility in promoting sustainable cocoa production
- 10 August 2024
- Published by Elsevier in Current Research in Food Science
- Vol. 9, 100818
Open AccessA critical review of consumer responsibility in promoting sustainable cocoa production